Objective To determine the etiologies of myonecrosis in oncology patients and to assess interobserver variability in interpreting its MRI features. Materials and methods Pathology records in our tertiary cancer hospital were searched for proven myonecrosis, and MRIs of affected regions in those patients were identified. MRI reports that suggested myonecrosis were also identified. Each MRI was reviewed independently by 2 out of 6 readers to assess anatomical site, size, and signal intensities of muscle changes, and the presence of the previously reported stipple sign (enhancing foci within a region defined by rim enhancement). The stipple sign was assessed again, weeks after a training session. Cohen kappa and percentage agreement were calculated. Medical records were reviewed for contemporaneous causes of myonecrosis. Results MRI reports in 73 patients suggested the diagnosis of myonecrosis; pathological proof was available in another 2. Myonecrosis was frequently associated with radiotherapy (n = 34 patients, 45 %); less frequent causes included intraoperative immobilization, trauma, therapeutic embolization, ablation therapy, exercise, and diabetes. Myonecrosis usually involved the lower extremity, the pelvis, and the upper extremity; mean size was 13.0 cm. The stipple sign was observed in 55-100 % of patients at first assessment (κ = 0.09-0.42; 60-80 % agreement) and 55-100 % at second (κ = 0.0-0.58; 72-90 % agreement). Enhancement surrounded myonecrosis in 55-100 % patients (κ = 0.03-0.32; 58-70 % agreement). Conclusion Myonecrosis in oncology patients usually occurred after radiotherapy, and less commonly after intraoperative immobilization, trauma, therapeutic embolization, ablation therapy, exercise, or diabetes. Although interobserver variability for MRI features of myonecrosis exists (even after focused training), a combination of findings facilitates diagnosis and conservative management.
Introduction
Acute muscle necrosis (myonecrosis) has commonly been described in the context of poor glycemic control in diabetic patients [1] . Diabetic myonecrosis manifests on MRI as a poorly defined, mass-like region of hyperintense signal on T2-weighted images and isointense to hypointense signal on T1-weighted images; associated perifascial, perimuscular, or subcutaneous edema may also be seen, usually in a lower extremity [1] [2] [3] . Thought to result from arterial damage, myonecrosis can have various other vascular causes, such as severe ischemia, sickle cell crisis, compartment syndrome, and crush injury [4] .
Evaluation of acute myonecrosis with imaging has received relatively little attention in the radiology literature. One MRI finding, the stipple sign, has been reported to allow differentiation between acute necrosis and acute ischemia of muscle [5, 6] . The stipple sign refers to dot-like, streaky, or curvilinear enhancing foci within a region of muscle separated from normal muscle by an enhancing rim [5, 6] (Fig. 1b) . Other findings, such as abnormal signal intensity within muscles on unenhanced images, are nonspecific, occurring in a wide range of inflammatory, infectious, neoplastic, and vascular pathological conditions, including acute ischemia of muscle. Because of these overlapping findings, inappropriate tissue sampling or treatment could be undertaken if the MRI findings of myonecrosis are not recognized.
In our practice in a tertiary cancer center, we have noted acute myonecrosis on MRI occurring in patients in several clinical scenarios. The purpose of this study was to determine the various etiologies of acute myonecrosis in oncology patients and to assess interobserver variability in scoring its MRI features.
Materials and methods
The institutional review board at our tertiary referral cancer hospital waived the requirement for informed consent for this retrospective study, which was HIPAA-compliant.
Study population and MRI examinations
A review of computerized pathology records identified all patients with pathologically proven myonecrosis diagnosed at our institution between January 2000 and September 2014. Also, all MRI radiology reports containing the keyword search terms Bmyonecrosis,^Bmuscle necrosis,^Bnecrotic muscle,^Bdead muscle,^or Brhabdomyolysis^at our institution during the same time period were identified electronically.
Patients were eligible for inclusion in the study population if they had a proven neoplasm and either (a) biopsy-proven myonecrosis and an MRI of the affected region, or (b) the report of a dedicated MRI at least suggesting the diagnosis of acute myonecrosis. The levels of diagnostic certainty included for the diagnosis in the radiology reports were based on our defined departmental lexicon for reporting certainty, which has been nearly uniformly used by all our radiologists since its introduction in 2009: Bpossible,^Bprobable,^or Bconsistent with( representing ∼50 %, ∼75 %, or >90 % certainty respectively, as noted by the reporting radiologist). Reports stating that myonecrosis was Bless likely^or Bunlikely^were not included (representing ∼25 % and <10 % certainty respectively).
Two of the 25 patients with myonecrosis noted in the pathology report (8 %) had undergone MRI of the affected region at our institution. Seventy-three other patients had MRI reports that suggested the presence of acute myonecrosis with at least a 50 % confidence level. Forty patients were male and 35 female (mean age, 52 years; range, 16-80 years). Primary tumors, in descending order of frequency, included bone and soft tissue (n = 27), genitourinary (n = 17), hematological (n = 9), gastrointestinal (n = 8), breast (n = 7), lung (n = 5), hepatobiliary (n = 5), and head and neck (n = 4) cancers, and neuroblastoma (n = 1). Eight of the 75 patients (11 %) had more than one type of tumor. Eighty of the total of 83 neoplasms (96 %) were malignant.
Sixty-one MRI studies were performed at 1.5 T and 14 at 3 T (General Electric). T1-weighted sequences were performed in all patients. Fat-suppressed T2-weighted fast spinecho sequences were performed in 65 studies, and short-tau inversion recovery sequences were available in 13. Seventyfour patients underwent fat-suppressed T1-weighted imaging after manual intravenous injection of gadolinium contrast material (0.1 mmol/kg); in 1 patient undergoing MRI of the neck, fat suppression was not used.
Image review
Magnetic resonance images from each patient were independently reviewed by 1 of 4 teams. Each team consisted of 1 of 2 Fig. 1 A 16-year-old boy with an osteosarcoma. The patient underwent a thoracotomy in left lateral decubitus position, resulting in immobilizationinduced myonecrosis. a Axial fat-suppressed T2-weighted MR image of the left thigh demonstrates diffuse intramuscular edema and subfascial fluid in the anterior compartment. b Axial post-contrast fat-suppressed T1-weighted image shows the stipple sign (arrow) within a well-defined geographic region of vastus lateralis and intermedius muscles, surrounded by a thin rim of intense enhancement. Note the lack of generalized enhancement throughout large portions of the region of myonecrosis. A restraining strap on the thigh in place throughout the operation presumably compressed the subjacent muscle against the underlying femur, resulting in this band-like region of myonecrosis faculty musculoskeletal radiologists (with 10 and 16 years of experience respectively), and 1 of 4 oncological imaging fellows. The fellow-faculty pairing was done to balance the level of reader experience on each team. Faculty radiologist 1 served on two teams: with fellow 1 to assess cases 1-20 and with fellow 2 to assess cases 21-38. Faculty radiologist 2 served on two other teams: with fellow 3 to assess cases 39-56 and with fellow 4 to assess cases 57-75.
The anatomical region affected and the largest dimension of muscle involvement (measured in any plane) on fluid-sensitive or gadolinium-enhanced sequences were recorded. Signal intensity characteristics of the region of muscle abnormality were graded as less than, equal to, or greater than muscle on T1-weighted images, and less than muscle, equal to muscle, greater than muscle but less than fluid, or equal to fluid on fluid-sensitive images. The extent of enhancement within the entire region of myonecrosis was assessed visually (0 %, >0-33 %, >33-66 %, >66-100 % of region), as was its intensity (much less than, somewhat less than, or similar to the signal of nearby vessels). The presence of fascial or intramuscular fluid collections and subcutaneous or intramuscular hyperintense signal on fluid-sensitive sequences were recorded. The presence of the stipple sign was assessed once on the post-contrast images, and then again at least 6 weeks later by the same readers after a reader training session; cases used in the training session were not from the study population.
Serial MRI scans, when available, were reviewed to assess for changes in the region of myonecrosis. Follow-up MRI scans were not used to confirm or refute the diagnosis of myonecrosis.
Medical record review
The electronic medical record for each patient was reviewed for patient age, gender, and tumor type. Potential contemporaneous precipitating factors for myonecrosis were recorded. Morbidity and mortality due to myonecrosis were assessed.
Statistical analysis
Cohen kappa statistic and percentage agreement were calculated as measures of interobserver agreement. Kappa values range from +1 (perfect agreement), through 0 (no agreement), to −1 (perfect disagreement). Kappa value < 0 is considered less than chance agreement; 0.01-0.20, slight agreement; 0.21-0.40, fair agreement; 0.41-0.60, moderate agreement; 0.61-0.80, substantial agreement; and 0.81-0.99, almost perfect agreement [7] . If a reader scores every case as positive (or every case as negative) for some feature, the kappa statistic cannot be calculated for that feature.
Results

Imaging findings and interobserver variability
Acute myonecrosis occurred most commonly in the lower extremity (28 of 75 patients, 37 %; Figs. 1, 2), pelvis (28, 37 %) , and upper extremity (13, 17 %); less common locations included the chest (3, 4 %), abdomen (2, 3 %), and head and neck (1, 1 %). Sixty (80 %) patients had a single site of myonecrosis within one anatomical region; 15 (20 %) had multiple sites (Fig. 3) ; and none had myonecrosis demonstrated in more than one region. The mean size of the signal abnormality associated with myonecrosis was 13.0 cm (range, 1.4-35.6 cm).
Magnetic resonance imaging findings, as categorized by each reader, are summarized in Table 1 , along with measures of interobserver variability. Myonecrosis was interpreted as isointense to muscle on T1-weighted sequences in most cases. On fluid-sensitive sequences, myonecrosis was most frequently hyperintense to muscle; in none of the cases were findings classified as isointense to muscle. Rarely, myonecrosis was classified as hyperintense to muscle on T1-weighted sequences, by only one reader in each group. Foci of enhancement were present within the region of myonecrosis in all cases (Fig. 4) . Enhancement within the region of myonecrosis was less than that of normal muscle; the extent and intensity of enhancement around the region of myonecrosis were variable. Subfascial fluid collections were uncommon.
Interobserver percentage agreement for signal intensity on T1-weighted and on fluid-sensitive sequences was high. Agreement for the stipple sign ranged from slight to moderate, according to Cohen kappa values, with a high percentage (Table 1) ; focused training resulted in only a small increase in interobserver agreement. At least 1 of the 2 study radiologists on each team recorded the stipple sign as being present in 68 of the 75 patients in the study (91 %). In the 7 cases in which neither study radiologist recorded the stipple sign as being present, a third, experienced musculoskeletal radiologist then reviewed the images. Gadolinium-enhanced images were available in 6 of those 7 cases; in 4 of the 6, the third radiologist scored the stipple sign as being present. Intense enhancement was present around a nonenhancing region of muscle in the 2 other cases with gadolinium-enhanced images, without internal enhancing foci; both patients had a clinical course consistent with myonecrosis rather than an abscess.
Follow-up MRI examinations were available in 32 patients (43 %). Muscle changes decreased in size in 22 patients (69 %), fatty atrophy developed within the muscles involved in 4 (13 %), and nonfatty atrophy (i.e., a decrease in muscle size, without an associated appearance of streaks of fat within that muscle) developed in 6 (19 %); none of the patients was scored as having more than one of these outcomes. The stipple sign was not present at follow-up imaging. None of the patients developed MRI-demonstrable fibrosis in the region of previous myonecrosis.
Clinical findings
Contemporaneous precipitating factors for myonecrosis were identified in 49 patients (65 %). External-beam radiotherapy to the region imaged (n = 34 patients, 45 %) was the most common such factor (Figs. 2, 3) ; the mean dose was 34 Gy (range, 15-60 Gy). Six of these patients received additional boost treatments (mean dose, 15 Gy; range, 3-20 Gy). The mean duration of the initial therapy was 15 days (range, 1-53 days); boost therapy extended treatment in 6 patients for a mean of 6 days (range, 2-15 days). The number of fractions delivered to the 34 patients varied: less than 5 fractions in 12 patients, 5-10 fractions in 11, 11-20 fractions in 1, and 21-30 fractions in 10. Boost doses were administered in less than 10 fractions in all 6 patients receiving boost therapy. Findings of myonecrosis on MRI obtained after radiation therapy were considered to be associated with the therapy, given the known long lag period for radiation effects on vessels to occur.
Other precipitating factors included prolonged intraoperative immobilization (n = 5 patients), local trauma (n = 5), focal ablation or therapeutic embolization (n = 3), intense exercise (n = 1), and poorly controlled diabetes with diabetic neuropathy (n = 1). MRI in the patients with the precipitants of immobilization, trauma, ablation/embolization, or exercise was obtained within days or weeks of the precipitating event.
Prolonged intraoperative immobilization (wherein the patient was unable to change position for several hours when anesthetized, unlike the usual turning that occurs during normal sleep) occurred in a patient who had been placed in the right lateral decubitus position for 7 h during a left posterolateral thoracotomy. The patient subsequently developed severe right lateral thigh pain, requiring narcotic analgesia; MRI of the thigh showed myonecrosis in the symptomatic region. A similar case involved a right posterolateral thoracotomy that lasted 6 h, with subsequent development of myonecrosis in the anterior compartment of the left thigh (Fig. 1) . Two patients developed right gluteal myonecrosis after a 7-h left radical nephrectomy and a 6-h left partial nephrectomy respectively. Another patient developed myonecrosis of the right gluteus maximus muscle after an 8-h surgical procedure to remove a sarcoma from the right groin.
Three patients with traumatic myonecrosis had chronic pressure on the affected region because of overall restricted mobility; each patient became acutely symptomatic, and MRI of the painful region was obtained. The MRI findings of acute myonecrosis in these cases were identical to those in the other patients, and are consistent with acute myonecrosis occurring in a region predisposed to myonecrosis due to chronic ischemia. In 2 other patients, myonecrosis resulted from iatrogenic 6 (33) 3 (17) 6 (32) 6 (32) 66-100 % 3 (15) 2 (10) 1 (6) 7 (39) 5 (28) 6 (33) 5 (26) 9 (47) Intensity of enhancement 1 (5) 1 (6) 2 (11) 2 (11) 0 (0) 4 (21) 1 ( One patient underwent radiofrequency ablation of a metastasis in the left inferior pubic ramus and subsequently developed adjacent myonecrosis with reactive hyperemia. In 2 patients, therapeutic embolization procedures were performed. The posterior division of the right internal iliac artery was embolized in a patient with sarcoma of the right iliac bone; myonecrosis subsequently developed in the ipsilateral gluteus maximus muscle. Branches of the profunda femoris artery were embolized to control an enlarging hematoma in the right thigh in a patient who was receiving anticoagulation therapy; myonecrosis subsequently occurred in the right rectus femoris and vastus medialis muscles.
Exercise-induced myonecrosis occurred in both inferior rectus abdominis muscles after a patient started a new exercise regimen involving multiple sit-ups (which involved those specific muscles ; Fig. 4) ; the patient had not received radiotherapy to this region.
Myonecrosis was considered idiopathic in 26 patients (35 %). None of the patients developed renal failure or other clinical signs of rhabdomyolysis.
Treatment for myonecrosis was required in 3 patients. Two underwent percutaneous drainage of an associated infection, and 1 underwent a decompression fasciotomy. No deaths were attributed to myonecrosis.
Discussion
Acute myonecrosis, representing the infarction of skeletal muscle, presents clinically with pain and swelling of the affected region. Although myonecrosis is infrequently encountered in clinical practice, it is important to distinguish it from other conditions because myonecrosis usually requires only conservative management [8] ; inappropriate intervention can be avoided if myonecrosis is recognized as such. Poorly controlled diabetes is the most well-known cause of myonecrosis, typically involving muscle compartments of the anterior thigh or posterior calf [2, [8] [9] [10] . MRI appearances reported in diabetic myonecrosis include diffuse muscle enlargement, partial loss of normal fatty intermuscular septa on T1-weighted images, fascial fluid collections, and subcutaneous edema [9] . Our study describes a range of other conditions associated with acute myonecrosis that were encountered in an oncology population.
Rhabdomyolysis, a related clinical syndrome, is characterized by extensive skeletal muscle injury, with an associated release of toxins into the systemic circulation and frequently complicated by acute kidney injury [5] . Extreme exercise, crush injuries, and medications (such as statins) are among the recognized causes of rhabdomyolysis [11, 12] . Diagnosis of rhabdomyolysis is usually established by the presence of elevated serum creatine kinase levels in the appropriate clinical context [13, 14] . Although not required for evaluation, MRI findings may support the diagnosis and assist with delineation of the extent and severity of muscle injury [6] .
Two distinct MRI patterns in rhabdomyolysis have been described based on muscle signal intensity and contrast enhancement characteristics [5, 6] . Type 1 changes, which represent potentially reversible muscle ischemia, manifest as homogeneous signal intensity that is isointense or hyperintense to muscle on T1-weighted images and hyperintense on T2-weighted and short-tau inversion recovery images, with enhancement after administration of gadolinium-based contrast material [6] . Type 2 changes, due to irreversible muscle necrosis, demonstrate predominantly heterogeneous signal intensity and rim enhancement, in addition to the stipple sign [5, 6] . Because of its high soft-tissue contrast, MRI is considered the best noninvasive method for identifying necrotic muscle [4, 8, 15] . The diagnosis of acute myonecrosis in our study, and in our daily clinical practice, was based Fig. 4 A 56-year-old woman with endometrial cancer. The patient developed severe abdominal pain after commencing exercise, due to myonecrosis of the rectus abdominis muscles. a Axial, post-contrast, fat-suppressed, T1-weighted MRI of the lower anterior abdominal wall demonstrates the stipple sign (arrowheads) surrounded by rim enhancement (arrows) within diffusely enlarged rectus abdominis muscles bilaterally. Those muscles do not show generalized enhancement; their signal intensity is less than that of the adjacent suppressed fat. b Axial, fat-suppressed, T2-weighted image shows diffusely, mildly increased T2 signal throughout the rectus muscles (arrows). Note that myonecrosis could not be diagnosed based on b alone predominantly on the stipple sign described in type 2 rhabdomyolysis [5, 6] : enhancing foci within a region of muscle surrounded by rim enhancement. That region otherwise shows less enhancement than normal muscle. The underlying biological assumption for the stipple sign is that dead muscle fibers do not enhance; the enhancing foci represent residual viable muscle fibers or inflammatory vessels [6] . The kappa values related to this and other signs of myonecrosis on MRI ranged from almost no agreement to substantial agreement, and the values for the stipple sign increased only slightly after a focused training session. However, the diagnosis of myonecrosis was suggested by the initial radiologist reporting each of the 75 study MRI examinations, and also by at least 1 of the 2 study radiologists in 91 % of those cases. This latter statistic served as a surrogate for consensus readings, which can be adversely influenced by the strength of the readers' personalities and the relative power structure of their relationship. Also, low kappa values are expected to arise when a finding is of either low or high prevalence [16] . The stipple sign and some other imaging features were very common findings in our study, resulting in low kappa values; however, the percentage agreement was high. We believe that the results of our study remain useful and valid despite some unavoidable uncertainty related to a lack of pathological proof-a standard not likely to be obtained in any study of this entity.
Myonecrosis was interpreted as isointense to normal muscle on T1-weighted sequences in most of the cases in our study, indicating that it would be difficult to recognize myonecrosis on this sequence alone. Rarely, myonecrosis was categorized as hyperintense to muscle on such sequences, which could be related to the presence of methemoglobin from hemorrhage, by only one of the readers in each group; intramuscular hemorrhage thus seems to be unusual or not extensive in acute myonecrosis.
Conversely, none of our cases was categorized by the readers as isointense to muscle on fluid-sensitive sequences. On these sequences, myonecrosis was most frequently hyperintense to normal muscle, which probably reflects the presence of edema. Such signal hyperintensity is obviously not specific for myonecrosis, as it also may occur, for example, in ischemic muscle, infectious or inflammatory myositis [4] , or after trauma.
Soft-tissue and bone sarcomas were the most common tumor types in our patient study group, likely because subspecialized musculoskeletal radiologists interpret the follow-up MRI of musculoskeletal sarcoma patients at our institution. This subgroup of radiologists may be more likely to recognize myonecrosis than other radiologists. Such a bias would not likely affect the validity of our results, however.
Myonecrosis occurred after external-beam radiotherapy to the region in nearly half of our study patients (Figs. 2, 3) . Radiation-induced myonecrosis has been described only rarely, as skeletal muscles are typically considered radioresistant at therapeutic doses [17] [18] [19] . A postulated pathogenesis for such myonecrosis, based on limited data, is ischemia resulting from vascular collagen proliferation that occurs within 10 months of exposure [17] . Recent technological advances in radiation oncology, most notably the ability to distribute the radiation dose more precisely in three dimensions to conform to the tumor morphology, allow increasingly high doses to be delivered to target tissues in fewer treatment fractions while minimizing damage to adjacent normal tissue [20] . Of 34 patients in our study with radiotherapy-associated myonecrosis, 23 received their radiotherapy in ten or fewer fractions; all 6 patients who underwent additional boost treatment also received that therapy in fewer than ten fractions. The increased use of MRI after radiotherapy may account for the increased demonstration and recognition of this therapy-associated effect.
Myonecrosis due to immobilization during prolonged surgery is usually reported in the context of neurosurgical spinal surgery, and in bariatric and urological procedures [21] [22] [23] . In our study, 5 cases of myonecrosis occurred after prolonged immobilization during thoracic, urological, and orthopedic operations (Fig. 1 ). This risk of such surgical morbidity can be minimized by ensuring appropriate intraoperative padding of the patient, minimizing operative times, and obtaining serial intraoperative serum creatine phosphokinase measurements in patients at risk; aggressive hydration can be administered if serum levels rise above a defined threshold [22] .
Increasingly, minimally invasive therapies such as arterial embolization and focal ablation are employed in the treatment of various primary or metastatic neoplasms, including hepatic, musculoskeletal, renal, and pulmonary tumors. For example, preoperative embolization may be performed to control intraoperative bleeding from hypervascular lesions such as metastases from renal or thyroid cancer. Focal ablative therapies, including cryoablation, radiofrequency ablation, and microwave ablation, lead to cellular necrosis and architectural tissue destruction by thermal effects on tumor cells [24] [25] [26] . Although often associated with lower morbidity compared with extensive open surgery, these therapies can cause complications related to thermal damage of the surrounding tissues, including skin necrosis [27, 28] . Acute myonecrosis can also occur, and has been reported to affect the diaphragm after radiofrequency ablation of hepatocellular carcinoma at the dome [29] . Embolization has also been implicated in cases of acute myonecrosis, principally due to the nontarget embolization of arteries supplying skeletal muscle [30] , or as a complication of embolization to control hemorrhage in severe pelvic fractures [31, 32] . Patients who have had previous radiotherapy are at an increased risk of myonecrosis in this setting [30] .
Trauma resulting from intense exercise (Fig. 4) or repeated intramuscular injections are relatively rarer causes of myonecrosis [33] . Necrotizing soft-tissue infections, such as those associated with Clostridia species, can also lead to myonecrosis [34, 35] ; no such case was found in our study.
Follow-up MRI in our study revealed a decrease in the size of the myonecrosis in 69 % of cases. In 31 %, atrophy occurred in regions of acute myonecrosis. Others have described follow-up MRI findings in regions of necrotic muscle, including interval decreases in signal intensity on both T1-weighted and fluid-sensitive images, without contrast enhancement [5] -findings attributed to the development of intramuscular fibrosis and/or hemosiderin deposition from old hemorrhage. In our study, only 3 patients required treatment (drainage of an associated infection, or decompression fasciotomy) for myonecrosis, and no deaths were directly attributed to myonecrosis. The time to the diagnosis of myonecrosis in our study largely depended on when the MRI happened to be obtained. The indication for the MRI examinations in our study was often not related to the myonecrosis, such as evaluation for a recurrent or metastatic tumor. Note that small regions of myonecrosis are expected to resorb over time, with no residua. Lack of abnormality at follow-up MRI would not indicate that the original MRI was false-positive for myonecrosis.
Another potential late sequela of acute myonecrosis is calcific myonecrosis, a rare condition characterized by the latent formation of a dystrophic calcified mass [36] . The hypothesized pathogenesis implicates post-traumatic ischemia and cystic degeneration of muscle. On MRI, the lesion typically manifests as a well-circumscribed mass, located along the course of a muscle group, with central fluid [36] ; the necrotic mass does not enhance [37, 38] , and dense calcification may manifest as a signal void on MRI. Blooming artifact from calcium may be visible on gradient-echo sequences, and a subtle, feathery periosteal reaction may be evident on fluidsensitive images [36] . Calcification was not assessed at CT or radiography in this study, as the clinical scenario and the MRI appearances were those of acute myonecrosis, not a centrally cystic mass.
Most of the MRI examinations reviewed in this study demonstrated increased signal intensity in the affected muscle(s) on fluid-sensitive images. The differential diagnosis for such a finding is broad, and includes trauma, infectious myositis, autoimmune polymyositis, dermatomyositis, subacute denervation, compartment syndrome, early myositis ossificans, and metastasis [4] . Gadolinium-based contrast material facilitated the differentiation of myonecrosis from these other potential etiologies by demonstrating non-enhancing, dead muscle tissue (i.e., myonecrosis). An intramuscular abscess could show peripheral enhancement on MRI, but would show fluid signal centrally-a finding not present in myonecrosis. Also, an abscess would not show internal foci of enhancement as occurs in myonecrosis, and the clinical findings differ with an abscess. Similarly, intramuscular metastasis with extensive central necrosis may show mostly peripheral enhancement, but would appear cystic in regions of necrosis, with no internal foci of enhancement.
The retrospective design of this study resulted in the unavoidable associated biases in patient selection, and nonuniform imaging techniques. The key words chosen to find reports that at least suggested myonecrosis may have resulted in additional cases being missed if the reporting radiologist had used other words to describe the condition. Some patients with MRIs reported as having Bpossible^or Bprobablem yonecrosis may in fact have had a condition that was not myonecrosis. However, to our knowledge, the constellation of MRI findings used to suggest the diagnosis of myonecrosis has not been reported in other conditions. Because of the lack of pathological proof, we chose not to include cases that the original interpreting radiologist considered Bless likely^or Bunlikely.^If the radiologist had low confidence in the diagnosis, the probability of including cases of conditions other than myonecrosis would be high, and thus dilute the results of our study. Of note, each of the 73 cases without pathological proof was identified as being suggestive of myonecrosis by a faculty radiologist, which was a requirement for inclusion in the study. At least 1 of the 2 study radiologists on each team recorded the stipple sign as being present in 91 % of all patients in the study. Thus, nearly all cases were deemed to be at least suggestive of myonecrosis by at least two radiologists. We do not believe that variations in MRI technique would have substantially altered the results.
Study readers were not blinded to the fact that the MRI studies had been reported as showing suspected myonecrosis; the purpose of the study was to assess interobserver variability, not the sensitivity or specificity of the various imaging findings. Four of the readers were oncological imaging fellows without subspecialty training in general musculoskeletal radiology; although such a lack of training might be regarded as a limitation, it also makes our findings more relevant and applicable to the large number of nonmusculoskeletal radiologists who read MRIs that usually do happen to include muscle. Only two pathologically proven cases of myonecrosis with dedicated MRI were available, precluding additional validation of the stipple sign as an imaging marker of muscle necrosis. However, the stipple sign has been previously reported with histopathological correlation [5, 6] , and no other plausible cause is known to the authors. Indeed, it is reassuring that only 2 patients in our study with MRI findings of myonecrosis underwent biopsy of the muscle, as the referring physicians accepted this imaging diagnosis as concordant with the clinical scenario in all other cases. Multivariate analysis of the various imaging features was not performed in our study. Although several clinical conditions known to be associated with myonecrosis were identified in our oncological cohort, this study does not establish causation; however, the temporal associations with myonecrosis and the contemporaneous clinical scenarios were compelling. The number of cases associated with radiotherapy was too small to allow subgroup analysis based on radiotherapy dose rates or techniques. The possibility that chemotherapy might potentitate the effects of other factors in the development of myonecrosis was not assessed in this study, given the numerous types and various temporal courses of such therapies received by the patients.
Conclusion
Acute myonecrosis in oncology patients most frequently occurred after radiotherapy, and less commonly after intraoperative or other immobilization; focal trauma; therapeutic embolization or ablation; intense exercise; or in patients with diabetes. Although interobserver variability for individual MRI features of acute myonecrosis exists (even after focused training), recognition of a combination of findings-enhancing foci within a region of otherwise nonenhancing muscle, surrounded by an enhancing rim-should facilitate this diagnosis. Our findings emphasize the importance of the awareness of the clinical context when considering a diagnosis of acute myonecrosis on MRI. Increased knowledge of the etiologies and MRI features of acute myonecrosis may prevent unnecessary tissue sampling and facilitate conservative management.
